Intra-Cellular Therapies, Inc. Gains 193.49%

Mon 23 Dec 19 at 05:30 PM
Intra-Cellular Therapies, Inc. Gains 193.49%

Intra-Cellular Therapies, Inc. (ITCI:NASDAQ) rocketted at $36.51, representing a gain of 193.5%. The stock appeared on our News Catalysts scanner on Mon 23 Dec 19 at 03:32 PM in the 'BIOTECH' category. From Mon 02 Dec 19, the stock recorded 57.14% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Intra-Cellular Therapies, Inc. (ITCI:NASDAQ)

Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.

Share